Cavan John T 4
4 · Hepion Pharmaceuticals, Inc. · Filed Nov 30, 2020
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-11-25$1.62/sh+4,500$7,290→ 4,800 total
4 · Hepion Pharmaceuticals, Inc. · Filed Nov 30, 2020
Common Stock